Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SFPP vs Diclofenac Gel in Knee Osteoarthritis
NCT03434197Phase 3Completed
- Sponsor
- Taisho Pharmaceutical
- Start
- Feb 2018
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of esflurbiprofen in osteoarthritis (OA), sponsored by Taisho Pharmaceutical. Started Feb 2018; status: completed.
02
Drugs
esflurbiprofen
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03434197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03434197.